Subscribe

Risk Factors for Atazanavir Urolithiasis in HIV-Positive Patient

Purpose:

To identify an HIV-positive patient who may be at risk for urolithiasis while being treated with atazanavir.

Specialty:

Nephrology, Urology, Obstetrics & Gynecology, Pedatrics, Genetics
Clinical Laboratory
Clinical Pharmacology & Toxicology

Objective:

risk factors, selection

ICD-10:

B23.8, T37.9, N20.9

Description:

Couzigou et al reported risk factors for urolithiasis in HIV-positive patients treated with the protease inhibitor atazanavir. These can help identify a patient at increase risk for urinary tract lithiasis and may suggest ways to reduce the risk. The authors are from multiple hospitals in France.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone